Pediatric oncology for the general pediatrician

作者: Koenraad K. Norga

DOI: 10.1007/S00431-010-1389-Y

关键词:

摘要: Since its establishment as a pediatric subspecialty oncology has become the near exclusive domain of specialized tertiary centers. This greatly aided progress in field with formation exemplary and highly focused international consortia that have continued to streamline clinical research efforts. Recently, rate terms further improvements overall outcome paradoxically slowed. Novel strategies are therefore needed assure advances. On one hand, global subspecialists will continue focus on development much improved therapies for those disease groups not yet seen their prognosis brighten, other there is trend invest joint-care initiatives cost-effective access standard therapy all. require closer involvement general pediatrician certain aspects cancer care broadest sense. We hope upcoming series aid this process by highlighting selected topics likely gain even more relevance years come. They include: screening predisposition syndromes; molecular diagnosis risk-adjustment acute leukemia childhood; an overview new agents development; impact treatment fertility available preservation options.

参考文章(9)
Matthew Meyerson, Stacey Gabriel, Gad Getz, Advances in understanding cancer genomes through second-generation sequencing Nature Reviews Genetics. ,vol. 11, pp. 685- 696 ,(2010) , 10.1038/NRG2841
Judith Frances Margolin, Molecular diagnosis and risk-adjusted therapy in pediatric hematologic malignancies: a primer for pediatricians European Journal of Pediatrics. ,vol. 170, pp. 419- 425 ,(2011) , 10.1007/S00431-011-1424-7
Tim Eden, Ching-Hon Pui, Martin Schrappe, Gianni Tognoni, Giuseppe Masera, All children have a right to full access to treatment for cancer. The Lancet. ,vol. 364, pp. 1121- 1122 ,(2004) , 10.1016/S0140-6736(04)17089-X
Alexis Teplick, Megan Kowalski, Jaclyn A. Biegel, Kim E. Nichols, Educational paper: screening in cancer predisposition syndromes: guidelines for the general pediatrician. European Journal of Pediatrics. ,vol. 170, pp. 285- 294 ,(2011) , 10.1007/S00431-010-1377-2
A.D. Henschel, L.G. Rothenberger, J. Boos, Randomized Clinical Trials in Children - Ethical and Methodological Issues Current Pharmaceutical Design. ,vol. 16, pp. 2407- 2415 ,(2010) , 10.2174/138161210791959854
Leslie L. Robison, Gregory T. Armstrong, John D. Boice, Eric J. Chow, Stella M. Davies, Sarah S. Donaldson, Daniel M. Green, Sue Hammond, Anna T. Meadows, Ann C. Mertens, John J. Mulvihill, Paul C. Nathan, Joseph P. Neglia, Roger J. Packer, Preetha Rajaraman, Charles A. Sklar, Marilyn Stovall, Louise C. Strong, Yutaka Yasui, Lonnie K. Zeltzer, The Childhood Cancer Survivor Study: A National Cancer Institute–Supported Resource for Outcome and Intervention Research Journal of Clinical Oncology. ,vol. 27, pp. 2308- 2318 ,(2009) , 10.1200/JCO.2009.22.3339
Malcolm A. Smith, Nita L. Seibel, Sean F. Altekruse, Lynn A.G. Ries, Danielle L. Melbert, Maura O'Leary, Franklin O. Smith, Gregory H. Reaman, Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century Journal of Clinical Oncology. ,vol. 28, pp. 2625- 2634 ,(2010) , 10.1200/JCO.2009.27.0421
Terzah M. Horton, Stacey L. Berg, Educational paper. The development of new therapies for pediatric oncology. European Journal of Pediatrics. ,vol. 170, pp. 555- 559 ,(2011) , 10.1007/S00431-010-1374-5